Affiliation:
1. Kuban State Medical University, Ministry of Health of Russia, Krasnodar
Abstract
Influenza and acute respiratory viral infections annually lead to a seasonal increase in morbidity with disability. Search for effective and safe drugs for their specific treatment is an urgent task. The Russian herbal remedy Hiporhamin has successfully passed the necessary trials for registration as an agent for the treatment of viral infections in adults and children. The distinctive properties of Hiporhamin are broad-spectrum antiviral activity against a number of RNA and DNA viruses, the presence of antimicrobial properties against a number of pathogenic microorganisms, and the established interferon-inducing effect. This set of different properties, including chemotherapeutic activity, effects on different types of pathogens of infectious diseases, and beneficial effects on the macroorganism in the absence of side (toxic) events, provides a wide range of therapeutic efficacy of the drug in the clinic and the possibility of its clinical application in both adults, including pregnant women, and children at the age of 3 years.
Publisher
Russian Vrach, Publishing House Ltd.
Reference40 articles.
1. СанПиН 3.3686-21 «Санитарно-эпидемиологические требования по профилактике инфекционных болезней». XXXIV. Профилактика гриппа и других острых респираторных вирусных инфекций (постановление Главного государственного санитарного врача РФ от 28.01.2021 №2) [SanPiN 3.3686-21 «Sanitarno-epidemiologicheskie trebovaniya po profilaktike infektsionnykh boleznei». XXXIV. Profilaktika grippa i drugikh ostrykh respiratornykh virusnykh infektsii (postanovlenie Glavnogo gosudarstvennogo sanitarnogo vracha RF ot 28.01.2021 №2) (in Russ.)]. URL: https://sudact.ru/law/postanovlenie-glavnogo-gosudarstvennogo-sanitarnogo-vracha-rf-ot_1377/sanpin-3.3686-21/xxxiv/
2. О состоянии санитарно-эпидемиологического благополучия населения в Российской Федерации в 2021 году: Государственный доклад. М.: Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека, 2022; 340 с. [O sostoyanii sanitarno-epidemiologicheskogo blagopoluchiya naseleniya v Rossiiskoi Federatsii v 2021 godu: Gosudarstvennyi doklad. M.: Federal'naya sluzhba po nadzoru v sfere zashchity prav potrebitelei i blagopoluchiya cheloveka, 2022; 340 р. (in Russ.)]. URL: https://www.rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=21796
3. Грипп у взрослых: клинические рекомендации Минздрава России от 28.12.2022; 70 с. [Gripp u vzroslykh: klinicheskie rekomendatsii Minzdrava Rossii ot 28.12.2022; 70 р. (in Russ.)]. URL: https://diseases.medelement.com/disease/грипп-у-взрослых-кп-рф-2022/17526
4. Пшеничная Н.Ю., Булгакова В.А., Волчкова Е.В. и др. Обзор текущих и перспективных направлений противовирусной терапии гриппа и острых респираторных вирусных инфекций в России. Тер арх. 2019; 91 (11): 105–9 [Pshenichnaya N.Y., Bulgakova V.A., Volchkova E.V. et al. Review of current and future directions of antiviral therapy of influenza and acute respiratory viral infections in Russia. Ter arkh. 2019; 91 (11): 105–9 (in Russ.)]. DOI: 10.26442/00403660.2019.11.000454
5. Зубкова Т.Г., Токин И.И., Карнаухова Е.Ю. и др. Этиотропная терапия и химиопрофилактика гриппа ингибиторами нейраминидазы. Медицинский совет. 2019; 21: 232–8 [Zubkova T.G., Tokin I.I., Karnaukhova E.Yu., et al. Etiotropic therapy and chemoprophylaxis of influenza with neuraminidase inhibitors. Medical Council. 2019; 21: 232–8 (in Russ.)]. DOI: 10.21518/2079-701X-2019-21-232-238